Immunome, Inc. ( IMNM) - Key Metrics
IMNM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.65 | -$0.54 | -$0.56 |
| 2026Q1 | $0 | -$0.48 | -$0.52 | -$0.54 |
| 2025Q4 | $0 | -$0.80 | -$0.55 | -$0.59 |
| 2025Q3 | $0 | -$0.65 | -$0.46 | -$0.47 |
| 2025Q2 | $0.05 | -$0.50 | -$0.57 | -$0.58 |
IMNM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.15 |
| 2026Q1 | 0% | -11.39 |
| 2025Q4 | 0% | -7.07 |
| 2025Q3 | 0% | -4.50 |
| 2025Q2 | 0% | -4.65 |
IMNM
Price: $27.20
52 week price:
Earnings Per Share: -2.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8759
Market Capitalization: 3.0 billion